Hyewon Chung

806 total citations
45 papers, 592 citations indexed

About

Hyewon Chung is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hyewon Chung has authored 45 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hyewon Chung's work include Drug Transport and Resistance Mechanisms (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Treatment and Management (5 papers). Hyewon Chung is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Treatment and Management (5 papers). Hyewon Chung collaborates with scholars based in South Korea, Ethiopia and United States. Hyewon Chung's co-authors include Kyung‐Sang Yu, Hyejin Lee, Yeon‐Ah Sung, Seo Hyun Yoon, Joo‐Youn Cho, Jee-Young Oh, Jae‐Yong Chung, SeungHwan Lee, In‐Jin Jang and Kyungah Jeong and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Hyewon Chung

43 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyewon Chung South Korea 16 160 128 121 73 69 45 592
Seongmin Kim South Korea 17 120 0.8× 212 1.7× 87 0.7× 72 1.0× 202 2.9× 66 841
Huiqin Zhang China 13 223 1.4× 165 1.3× 198 1.6× 69 0.9× 169 2.4× 38 764
Alexander Smith United Kingdom 13 130 0.8× 120 0.9× 119 1.0× 383 5.2× 98 1.4× 22 821
Isao Ikemoto Japan 13 367 2.3× 79 0.6× 303 2.5× 37 0.5× 76 1.1× 45 734
Sahar M. El-Haggar Egypt 12 56 0.3× 121 0.9× 80 0.7× 15 0.2× 47 0.7× 32 443
Bedia Ağaçhan Türkiye 20 50 0.3× 276 2.2× 73 0.6× 40 0.5× 199 2.9× 46 1.0k
Ebru Kale Türkiye 12 41 0.3× 79 0.6× 54 0.4× 64 0.9× 68 1.0× 46 441
Mahta Mazaheri Iran 19 27 0.2× 195 1.5× 52 0.4× 52 0.7× 108 1.6× 65 735
Xiaoling Yang China 15 66 0.4× 351 2.7× 44 0.4× 125 1.7× 62 0.9× 45 923

Countries citing papers authored by Hyewon Chung

Since Specialization
Citations

This map shows the geographic impact of Hyewon Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyewon Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyewon Chung more than expected).

Fields of papers citing papers by Hyewon Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyewon Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyewon Chung. The network helps show where Hyewon Chung may publish in the future.

Co-authorship network of co-authors of Hyewon Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Hyewon Chung. A scholar is included among the top collaborators of Hyewon Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyewon Chung. Hyewon Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, So‐hyeon, Yeon‐Ah Sung, Young Sun Hong, et al.. (2025). The association between phenotypes of polycystic ovary syndrome and metabolic dysfunction-associated fatty liver disease. Frontiers in Endocrinology. 16. 1480528–1480528.
2.
Xiao, Na, Yanxia Chen, Can Li, et al.. (2025). Reverse genetics-derived cattle H5N1 virus from Clade 2.3.4.4b shows enhanced systemic infectivity and pathogenicity than an older Clade 1 H5N1 virus in BALB/c mice. Emerging Microbes & Infections. 14(1). 2475836–2475836. 2 indexed citations
3.
Kim, Tae‐Eun, et al.. (2024). Research on unintroduced new drugs in South Korea from 2011 to 2020: approaches to prioritization and strategy. Translational and Clinical Pharmacology. 32(4). 187–187.
4.
5.
Chung, Hyewon, et al.. (2023). Effects of Simvastatin on Pharmacokinetics and Anticoagulant Effects of Dabigatran in Healthy Subjects. Pharmaceuticals. 16(3). 364–364. 1 indexed citations
6.
Park, Jin‐Woo, Hyewon Chung, Kyoung‐Ah Kim, et al.. (2022). Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran. Pharmaceutics. 14(2). 257–257. 5 indexed citations
7.
Kwon, Jung Won, Juha Song, Hyewon Chung, et al.. (2022). Liposomal Dexamethasone Reduces A/H1N1 Influenza-Associated Morbidity in Mice. Frontiers in Microbiology. 13. 845795–845795. 7 indexed citations
8.
Park, Jin‐Woo, Hyewon Chung, Kyoung‐Ah Kim, et al.. (2021). ABCG2 Single Nucleotide Polymorphism Affects Imatinib Pharmacokinetics in Lower Alpha-1-Acid Glycoprotein Levels in Humans. Frontiers in Pharmacology. 12. 658039–658039. 2 indexed citations
9.
Park, In Hwan, Jin‐Woo Park, Hyewon Chung, et al.. (2021). Development and validation of LC–MS/MS method for simultaneous determination of dabigatran etexilate and its active metabolites in human plasma, and its application in a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 203. 114220–114220. 6 indexed citations
10.
Chung, Hyewon, et al.. (2021). Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication. British Journal of Clinical Pharmacology. 88(1). 138–144. 33 indexed citations
11.
12.
13.
Hong, So‐hyeon, Young Sun Hong, Kyungah Jeong, et al.. (2020). Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes. Scientific Reports. 10(1). 10479–10479. 21 indexed citations
14.
Kim, Da Jung, Hyewon Chung, Sang Chun Ji, et al.. (2019). Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways. Metabolomics. 15(3). 30–30. 18 indexed citations
15.
Chung, Hyewon, Jaeseong Oh, Seo Hyun Yoon, et al.. (2018). A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study. PLoS ONE. 13(1). e0191258–e0191258. 21 indexed citations
16.
Chung, Hyewon, Anhye Kim, Kyoung Soo Lim, et al.. (2016). Pharmacokinetics and effect on the corrected QT interval of single-dose escitalopram in healthy elderly compared with younger adults. International Clinical Psychopharmacology. 32(1). 20–26. 1 indexed citations
17.
Chung, Hyewon, Howard Lee, Kyoung Soo Lim, et al.. (2015). A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles. Drug Design Development and Therapy. 9. 2609–2609. 23 indexed citations
18.
Lee, Hyejin, Jee-Young Oh, Yeon‐Ah Sung, et al.. (2015). Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome. Human Reproduction. 30(3). 723–731. 67 indexed citations
19.
Shin, So‐Jin, Hyewon Chung, Sang‐Hoon Kwon, et al.. (2015). The Feasibility of a Modified Method of Laparoscopic Transabdominal Cervicoisthmic Cerclage During Pregnancy. Journal of Laparoendoscopic & Advanced Surgical Techniques. 25(8). 651–656. 22 indexed citations
20.
Lee, Hyejin, et al.. (2006). Prevalence of Metabolic Syndrome in Young Korean Women with Polycystic Ovary Syndrome. 30(4). 285–285. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seongmin Kim Breakdown of academic impact, for papers by Huiqin Zhang Breakdown of academic impact, for papers by Alexander Smith Breakdown of academic impact, for papers by Isao Ikemoto Breakdown of academic impact, for papers by Sahar M. El-Haggar Breakdown of academic impact, for papers by Bedia Ağaçhan Breakdown of academic impact, for papers by Ebru Kale Breakdown of academic impact, for papers by Mahta Mazaheri Breakdown of academic impact, for papers by Xiaoling Yang
Rankless by CCL
2026